HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Angelini Sets Up In Germany As It Unveils ThermaCare Plans

Executive Summary

Angelini is looking to take its recently-acquired ThermaCare brand to the next level by establishing a direct base in Germany to market the product and through a new distribution deal with Norway's Navamedic.

You may also be interested in...



People On The Move: Appointments At Stada And Angelini Pharma

A round-up of notable consumer heath appointments: Stada has hired Sanofi's Stéphane Jacqmin as head of emerging markets; and Angelini has appointed Gilead's Jacopo Andreose as CEO of its Pharma business.

EU Business Round-Up: Vision Acquires Nutriment, P&G Researching Sustainable Supply Chains, ThermaCare Relaunched In Nordics

The latest European business news: Vision Healthcare grows subscription supplements offering with Nutriment acquisition; P&G opens sustainable supply chains innovation center in Germany; and Navamedic relaunches global pain-relief brand ThermaCare in the Nordics.

EU Business Round-Up: Gilbert Grabs Grimberg, Navamedic Adds Brain Health Probiotic, Acino Acquires Russian Portfolio

Latest European consumer health business news: Laboratoires Gilbert strengthens its position in France with Grimberg acquisition; Norway's Navamedic secures distribution of brain health probiotic; and Switzerland's Acino gains two supplements popular in Russia.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

RS149889

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel